Literature DB >> 22569910

Cathepsin K preferentially solubilizes matured bone matrix.

Olivier Borel1, Evelyne Gineyts, Cindy Bertholon, Patrick Garnero.   

Abstract

Bone collagen undergoes a series of enzymatic and nonenzymatic posttranslational modifications with maturation. The aim of this study was to analyze the collagenolytic efficiency of cathepsin K in relation to the extent of bone collagen age. Bone collagen posttranslational maturation was induced in vitro by preincubating bovine fetal cortical bone specimens at 37 °C for different times. The collagen enzymatic cross-links pyridinoline (PYD) and deoxypyridinoline (DPD), the advanced glycation end product pentosidine (PEN), and the native (α) and β-isomerized C-telopeptide (CTX) isomers were measured in each bone specimen. After extraction, bone collagen was incubated with human recombinant cathepsin K at different concentrations and its collagenolytic activity was measured by the release of hydroxyproline. To assess the affinity of cathepsin K for isomerized and nonisomerized CTX isomers, incubation with cathepsin K was also performed in the presence of various concentrations of a specific inhibitor. We showed that preincubation of bone collagen at 37 °C induces a marked increase in the bone concentration of PYD, DPD, and PEN and of CTX isomerization as reflected by the ratio of α-/βCTX. This increase was associated with a parallel increase in the efficiency of cathepsin K to solubilize bone collagen. When cathepsin K was incubated in the presence of an inhibitor, the β-isomerized form of collagen from 3-month- and 8-year-old bovine bone was more susceptible to degradation than the native α form. These results suggest that the collagenolytic activity of cathepsin K may be increased toward more matured bone collagen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22569910     DOI: 10.1007/s00223-012-9604-7

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  6 in total

1.  Chondroitin sulfate promotes activation of cathepsin K.

Authors:  Peter A Lemaire; Lingyi Huang; Ya Zhuo; Jun Lu; Carolyn Bahnck; Shawn J Stachel; Steve S Carroll; Le T Duong
Journal:  J Biol Chem       Date:  2014-06-23       Impact factor: 5.157

Review 2.  The contribution of collagen crosslinks to bone strength.

Authors:  Patrick Garnero
Journal:  Bonekey Rep       Date:  2012-09-19

3.  The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.

Authors:  E Cavalier; P Bergmann; O Bruyère; P Delanaye; A Durnez; J-P Devogelaer; S L Ferrari; E Gielen; S Goemaere; J-M Kaufman; A Nzeusseu Toukap; J-Y Reginster; A-F Rousseau; S Rozenberg; A J Scheen; J-J Body
Journal:  Osteoporos Int       Date:  2016-03-30       Impact factor: 4.507

Review 4.  Cysteine cathepsin activity regulation by glycosaminoglycans.

Authors:  Marko Novinec; Brigita Lenarčič; Boris Turk
Journal:  Biomed Res Int       Date:  2014-12-21       Impact factor: 3.411

5.  Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone.

Authors:  Weiping Liang; Fuhao Wang; Qiuyan Chen; Jinlu Dai; June Escara-Wilke; Evan T Keller; Johann Zimmermann; Ni Hong; Yi Lu; Jian Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2019-06-06       Impact factor: 4.553

Review 6.  The Elusive Antifibrotic Macrophage.

Authors:  Adhyatmika Adhyatmika; Kurnia S S Putri; Leonie Beljaars; Barbro N Melgert
Journal:  Front Med (Lausanne)       Date:  2015-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.